# LYN

## Overview
LYN mutations have been reported in DLBCL but the rate is relatively rare in most cohorts. The mutation pattern in DLBCL and FL implies the preferential accumulation of *inactivating mutations*. *Without further support, this gene may be migrated to Tier 2.*
## History
```mermaid
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
    title Publication timing
      2018-05-01 : Chapuy : DLBCL
```

## Relevance tier by entity

|Entity|Tier|Description               |
|:------:|:----:|--------------------------|
|![DLBCL](images/icons/DLBCL_tier1.png) |1   |high-confidence DLBCL gene|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source        |frequency (%)|
|:------:|:--------------:|:-------------:|
|DLBCL |GAMBL genomes |2.29         |
|DLBCL |Schmitz cohort|1.70         |
|DLBCL |Reddy cohort  |1.30         |
|DLBCL |Chapuy cohort |5.56         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   | 1.641          | 0.000          |
|DLBCL |No  |No                   |10.031          |17.456          |
|FL    |No  |No                   | 0.000          | 0.000          |



View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/LYN_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/LYN_protein_hg38.html)

![](images/proteinpaint/LYN_ENST00000519728.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/LYN.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/LYN_hg38.html)

![](images/proteinpaint/LYN.svg)

## LYN Expression
![](images/gene_expression/LYN_by_pathology.svg)

<!-- FLAGGED FOR TIER 2 -->
<!-- ORIGIN: chapuyMolecularSubtypesDiffuse2018b -->
<!-- DLBCL: chapuyMolecularSubtypesDiffuse2018b -->

## References
1.  Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, Taylor-Weiner A, Coughlin CA, Hess JM, Pedamallu CS, Livitz D, Rosebrock D, Rosenberg M, Tracy AA, Horn H, van Hummelen P, Feldman AL, Link BK, Novak AJ, Cerhan JR, Habermann TM, Siebert R, Rosenwald A, Thorner AR, Meyerson ML, Golub TR, Beroukhim R, Wulf GG, Ott G, Rodig SJ, Monti S, Neuberg DS, Loeffler M, Pfreundschuh M, Trümper L, Getz G, Shipp MA. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018 May;24(5):679–690. PMCID: PMC6613387
